Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micromedex is a premier provider of evidence-based clinical decision support (CDS) and drug information, serving healthcare professionals in hospitals and clinical settings worldwide. The platform offers a suite of comprehensive databases, including DRUGDEX for drug monographs, POISINDEX for toxicology, and NeoFax for neonatal dosing, all of which are peer-reviewed and updated regularly. Originally established in 1974, Micromedex has been owned by several major entities, including Thomson Reuters and IBM, and is currently a core product line of Merative. Its solutions are designed to enhance medication safety, reduce clinical errors, and provide reliable medical knowledge at the point of care through seamless integration with electronic health records. The company's data is trusted by thousands of institutions globally for its depth, accuracy, and clinical relevance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micromedex.